Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

NCT03609216 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

237

Enrollment

OTHER

Sponsor class

Conditions

Infiltrating Bladder Urothelial Carcinoma
Stage II Bladder Urothelial Carcinoma
Stage III Bladder Urothelial Carcinoma

Interventions

DRUG: Gemcitabine Hydrochloride
DRUG: Cisplatin
BIOLOGICAL: Pegfilgrastim
PROCEDURE: Conventional Surgery
PROCEDURE: Radical Cystectomy
OTHER: Chemoradiotherapy

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]